UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~March 3031, ~~2023~~2024

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to _________

Commission File Number: 0-21609

Chase Packaging Corporation

(Exact name of registrant as specified in its charter)

Delaware

93-1216127

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

PO Box 126, Rumson NJ 07760

(Address of principal executive offices) (Zip Code)

(732) 741.1500

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act: None

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act. Yes ☒ No ☐

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class		Outstanding at ~~November~~May 1410, ~~2023~~2024
Common Stock, par value $.00001 per share		61,882,172 shares

Table of Contents

- INDEX -

		Page(s)
PART I - Financial Information:
ITEM 1.	Financial Statements:	3
	Condensed Balance Sheets (Unaudited) - September 30, 2023 and December 31, 2022	3
	Condensed Balance Sheets (Unaudited) - March 31, 2024 and December 31, 2023	3
	Condensed Statements of Operations (Unaudited) - Three and Nine months Ended September 30, 2023 and 2022	4
	Condensed Statements of Operations (Unaudited) - Three months ended March 31, 2024 and 2023	4
	Condensed Statements of Changes in Stockholders’ Equity (Unaudited) - Three and Nine months Ended September 30, 2023 and 2022	5
	Condensed Statements of Changes in Stockholders’ Equity (Unaudited) - Three months ended March 31, 2024 and 2023	5
	Condensed Statements of Cash Flows (Unaudited) - Nine months Ended September 30, 2023 and 2022	6
	Condensed Statements of Cash Flows (Unaudited) - Three months ended March 31, 2024 and 2023	6
	Notes to Interim Condensed Financial Statements (Unaudited)	7
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	11
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	13
ITEM 4.	Controls and Procedures	1413
PART II - Other Information:
ITEM 1.	Legal Proceedings.	1514
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	1514
ITEM 3.	Defaults upon Senior Securities.	1514
ITEM 4.	Mine Safety Disclosures.	1514
ITEM 5.	Other Information.	1514
ITEM 6.	Exhibits.	1514
SIGNATURES		1615
EXHIBITS

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements.

CHASE PACKAGING CORPORATION

CONDENSED BALANCE SHEETS

(Unaudited)

	September 30,			December 31,
	March 31,			December 31,
	2023			2022
	2024			2023
ASSETS
Current Assets
CURRENT ASSETS:
Cash and cash equivalents	$	~~402~~351,~~083~~388		$	~~441~~388,~~243~~171
Total Assets	$	402,083		$	441,243
TOTAL ASSETS	$	351,388		$	388,171
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES:
Current Liabilities
Accounts payable and accrued expenses	$	3,473		$	4,985
Accounts payable and accrued liabilities	$	855		$	477
TOTAL CURRENT LIABILITIES		3,473			4,985
Total Current Liabilities		855			477
COMMITMENTS AND CONTINGENCIES (Note 9)
Commitments and contingencies - Note 8
STOCKHOLDERS’ EQUITY:
Stockholders’ Equity
Preferred stock, $1.00 par value; 4,000,000 authorized: Series A 10% Convertible preferred stock; 50,000 shares designated; no shares issued and outstanding at March 31, 2024 and December 31, 2023		—			—
Preferred stock, $1.00 par value; 4,000,000 authorized: Series A 10% Convertible preferred stock; 50,000 shares designated; no shares issued and outstanding at September 30, 2023 and December 31, 2022		—			—
Common stock, $0.00001 par value; 200,000,000 shares authorized; 62,379,759 shares issued and 61,882,172 shares outstanding at March 31, 2024 and December 31, 2023		619			619
Common stock, $0.00001 par value; 200,000,000 shares authorized; 62,379,759 shares issued and 61,882,172 shares outstanding at September 30, 2023 and December 31, 2022		619			619
Treasury stock, $0.00001 par value 497,587 shares at March 31, 2024 and December 31, 2023		(49,759	)		(49,759	)
Treasury stock, $0.00001 par value 497,587 shares at September 30, 2023 and December 31, 2022		(49,759	)		(49,759	)
Additional paid-in capital		8,839,367			8,839,367
Additional paid-in capital		9,115,727			8,493,917
Accumulated deficit		(8,442,312	)		(8,407,041	)
Accumulated deficit		(8,665,359	)		(8,004,011	)
TOTAL STOCKHOLDERS’ EQUITY		347,915			383,186
Total Stockholders’ Equity		401,228			440,766
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	351,388		$	388,171
Total Liabilities and Stockholders’ Equity	$	402,083		$	441,243
The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

CHASE PACKAGING CORPORATION

CONDENSED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended						Nine Months Ended
	For The Three Months EndedMarch 31,
	September 30,						September 30,
	2024			2023
	2023			2022			2023			2022
NET SALES	$	—		$	—
Net Sales	$	—		$	—		$	—		$	—
OPERATING EXPENSES:
Operating Expenses
General and administrative expense		39,137			15,839
General and administrative expense		12,128			15,546			48,996			47,408
TOTAL OPERATING EXPENSES		39,137			15,839
Total Operating Expenses		12,128			15,546			48,996			47,408
LOSS FROM OPERATIONS		(39,137	)		(15,839	)
Loss From Operations		(12,128	)		(15,546	)		(48,996	)		(47,408	)
OTHER INCOME (EXPENSE)
Other Income (Expense)
Interest and other income		3,866			2,353
Interest and other income		3,018			1,688			9,458			1,966
Warrant modification expense		—			(621,810	)
Warrants modification expense		—			—			(621,810	)		—
TOTAL OTHER INCOME (EXPENSE)		3,866			(619,457	)
Total Other Income (Expense)		3,018			1,688			(612,352	)		1,966
LOSS BEFORE INCOME TAXES		(35,271	)		(635,296	)
Net Loss Before Income Taxes		(9,110	)		(13,858	)		(661,348	)		(45,442	)
Provision for income taxes		—			—
Income taxes		—			—			—			—
NET LOSS	$	(35,271	)	$	(635,296	)
Net Loss	$	(9,110	)	$	(13,858	)	$	(661,348	)	$	(45,442	)
BASIC AND DILUTED LOSS PER COMMON SHARE	$	(0.00	)	$	(0.01	)
Net Loss Per Common Share
BASIC AND DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING		61,882,172			61,882,172
Basic and Diluted	$	(0.00	)	$	(0.00	)	$	(0.01	)	$	(0.00	)
The accompanying notes are an integral part of these unaudited condensed financial statements.
Weighted Average Number of Common Shares Outstanding
Basic and Diluted		61,882,172			61,882,172			61,882,172			61,882,172
The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

CHASE PACKAGING CORPORATION

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

FOR THE THREE ~~AND NINE MONTHS~~ ENDED ~~SEPTEMBER~~MARCH 3031, ~~2023~~2024 AND ~~2022~~2023

(Unaudited)

	Common				Additional Paid-in		Accumulated			Treasury Stock						~~Total Stockholders’~~
	Shares		Amount		Capital		Deficit			Shares			Amount			~~Equity~~Total
Balance - January 1, 2022		61,882,172	$	619	$	8,493,917	$	(7,948,119	)		(497,587	)	$	(49,759	)	$	496,658
Balance at December 31, 2022		61,882,172	$	619	$	8,493,917	$	(8,004,011	)		(497,587	)	$	(49,759	)	$	440,766
Net loss for the three months ended March 31, 2022		—		—		—		(22,073	)		—			—			(22,073	)
Modification of warrants, expiration of 6,909,000 warrants extended to March 8, 2026		—		—		621,810		—			—			—			621,810
Balance - March 31, 2022		61,882,172	$	619	$	8,493,917	$	(7,970,192	)		(497,587	)	$	(49,759	)	$	474,585
Net loss for the three months ended March 31, 2023		—		—		—		(635,296	)		—			—			(635,296	)
Net loss for the three months ended June 30, 2022		—		—		—		(9,511	)		—			—			(9,511	)
Balance at March 31, 2023		61,882,172	$	619	$	9,115,727	$	(8,639,307	)		(497,587	)	$	(49,759	)	$	427,280
Balance - June 30, 2022		61,882,172	$	619	$	8,493,917	$	(7,979,703	)		(497,587	)	$	(49,759	)	$	465,074
Net loss for the three months ended September 30, 2022		—		—		—		(13,858	)		—			—			(13,858	)
Balance - September 30, 2022		61,882,172	$	619	$	8,493,917	$	(7,993,561	)		(497,587	)	$	(49,759	)	$	451,216

	Common				Additional Paid-in		Accumulated			Treasury Stock						~~Total Stockholders’~~
	Shares		Amount		Capital		Deficit			Shares			Amount			~~Equity~~Total
Balance - January 1, 2023		61,882,172	$	619	$	8,493,917	$	(8,004,011	)		(497,587	)	$	(49,759	)	$	440,766
Balance at December 31, 2023		61,882,172	$	619	$	8,839,367	$	(8,407,041	)		(497,587	)	$	(49,759	)	$	383,186
Modification of warrants, expiration of 6,909,000 warrants extended to March 7, 2026		—		—		621,810		—			—			—			621,810
Net loss for the three months ended March 31, 2024		—		—		—		(35,271	)		—			—			(35,271	)
Net loss for the three months ended March 31, 2023		—		—		—		(635,296	)		—			—			(635,296	)
Balance at March 31, 2024		61,882,172	$	619	$	8,839,367	$	(8,442,312	)		(497,587	)	$	(49,759	)	$	347,915
Balance - March 31, 2023		61,882,172	$	619	$	9,115,727	$	(8,639,307	)		(497,587	)	$	(49,759	)	$	427,280
Net loss for the three months ended June 30, 2023		—		—		—		(16,942	)		—			—			(16,942	)
Balance - June 30, 2023		61,882,172	$	619	$	9,115,727	$	(8,656,249	)		(497,587	)	$	(49,759	)	$	410,338
Net loss for the three months ended September 30, 2023		—		—		—		(9,110	)		—			—			(9,110	)
Balance - September 30, 2023		61,882,172	$	619	$	9,115,727	$	(8,665,359	)		(497,587	)	$	(49,759	)	$	401,228
The accompanying notes are an integral part of these unaudited condensed financial statements.

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

CHASE PACKAGING CORPORATION

CONDENSED STATEMENTS OF CASH FLOWS

(Unaudited)

	Nine Months Ended
	For The Three Months Ended
	September 30,
	March 31,
	2023			2022
	2024			2023
Cash Flows From Operating Activities
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss	$	(661,348	)	$	(45,442	)
Net loss	$	(35,271	)		(635,296	)
Adjustments to reconcile net loss from operations to net cash used in operating activities:
Warrants modification expense		~~621,810~~—			—621,810
Changes in operating assets and liabilities:
Change in operating assets and liabilities:
Accounts payable and accrued liabilities		378			—
Accounts payable and accrued expenses		(1,512	)		3,750	)
Net Cash Used in Operating Activities		(39,160	)		(45,442	)
Net cash used in operating activities		(36,783	)		(9,736	)
Cash Flows From Investing Activities		—			—
CASH FLOWS FROM INVESTING ACTIVITIES		—			—
Cash Flows From Financing Activities		—			—
CASH FLOWS FROM FINANCING ACTIVITIES		—			—
Net Decrease in Cash and Cash Equivalents		(39,160	)		(45,442	)
NET DECREASE IN CASH		(36,783	)		(9,736	)
Cash and Cash Equivalents, Beginning of Period		441,243			497,135
Cash, beginning of period		388,171			441,243
Cash and Cash Equivalents, End of Period	$	402,083		$	451,693
CASH, END OF PERIOD	$	351,388			431,507
Supplemental Disclosure of Cash Flow Information
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid during the period:
Cash paid for:
Interest paid	$	—		$	—
Interest	$	—		$	—
Income taxes paid	$	—		$	—
Income taxes	$	—		$	—
The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

CHASE PACKAGING CORPORATION

NOTES TO THE CONDENSED FINANCIAL STATEMENTS

(UNAUDITED)

~~SEPTEMBER~~MARCH ~~30, 2023 AND DECEMBER~~ 31, ~~2022~~2024

NOTE 1 - BASIS OF PRESENTATION:

Chase Packaging Corporation (“the Company”), a Delaware Corporation, previously manufactured woven paper mesh for industrial applications and polypropylene mesh fabric bags for agricultural use, and distributed agricultural packaging manufactured by other companies. Management’s plans for the Company include securing a merger or acquisition, raising additional capital, and other strategies designed to optimize shareholder value. However, no assurance can be given that management will be successful in its efforts. The failure to achieve these plans will have a material adverse effect on the Company’s financial position, results of operations, and ability to continue as a going concern.

The unaudited condensed financial statements included herein have been prepared by the Company, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in the financial statements prepared in accordance with generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures made are adequate to provide for fair presentation and a reasonable understanding of the information presented. The unaudited condensed financial statements should be read in conjunction with the financial statements and the related notes, as well as Management’s Discussion and Analysis of Financial Condition and Results of Operations, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, ~~2022~~2023, previously filed with the SEC.

In the opinion of management, all adjustments (which include normal recurring adjustments) necessary to present a fair statement of financial position as of ~~September~~March 3031, ~~2023~~2024, and results of operations and cash flows for the ~~nine~~three months ended ~~September~~March 3031, ~~2023~~2024 and ~~2022~~2023, as applicable, have been made. The results of operations for the ~~nine~~three months ended ~~September~~March 3031, ~~2023~~2024 are not necessarily indicative of the operating results for the full fiscal year ended December 31, ~~2023~~2024 or any future periods.

NOTE 2 - LIQUIDITY:

At ~~September~~March 3031, ~~2023~~2024 and December 31, ~~2022~~2023, the Company had cash and cash equivalents of $~~402~~351,~~083~~388 and $~~441~~388,~~243~~171, respectively, consisting of money market funds and U.S. Treasury Bills. Our net losses incurred for the ~~nine~~three months ended ~~September~~March 3031, ~~2023~~2024 and ~~2022~~2023, amounted to $~~661~~35,~~348~~271 and $45635,~~442~~296, respectively, and we had working capital of $~~401~~347,~~228~~915 and $~~440~~383,~~766~~186 at ~~September~~March 3031, ~~2023~~2024 and December 31, ~~2022~~2023, respectively. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.

NOTE 3 - SIGNIFICANT ACCOUNTING POLICIES AND RECENT ACCOUNTING PRONOUNCEMENTS:

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all highly liquid investments that are readily convertible into cash with a remaining maturity of ~~nine~~three months or less at the time of acquisition to be cash equivalents. The Company maintains its cash and cash equivalents balances with high credit quality financial institutions. As of ~~September~~March 3031, ~~2023~~2024 and December 31, ~~2022~~2023, the Company had cash in insured accounts in the amount of $1456,~~048~~172 and $~~141~~9,~~243~~721, respectively, and cash equivalents (Treasury and government securities) held in financial institutions that were uninsured by Federal Deposit Insurance Corporation in the amount of $~~388~~295,~~035~~216 and $~~300~~378,~~000~~450, respectively.

Table of Contents

Income Taxes

The asset and liability method is used in accounting for income taxes. Under this method, deferred tax assets and liabilities are recognized for operating loss and tax credit carry forwards and for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured assuming enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is recorded to reduce the carrying amounts of deferred tax assets unless it is more likely than not that such asset will be realized.

The Company follows FASB Interpretation of “Accounting for Uncertainty in Income Taxes.” At ~~September~~March 3031, ~~2023~~2024 and December 31, ~~2022~~2023, the Company evaluated its tax positions and did not have any unrecognized tax benefits. The Company’s practice is to recognize interest and/or penalties related to income tax matters in income tax expense. The Company currently has no federal or state tax examinations in progress.

Accounting for Stock Based Compensation

Stock-based compensation expense incurred by the Company for employees and directors is based on the employee model of ASC 718, and the fair market value of the award is measured at the grant date. Under ASC 718 employee is defined as “An individual over whom the grantor of a share-based compensation award exercises or has the right to exercise sufficient control to establish an employer-employee relationship based on common law as illustrated in case law and currently under U.S. “tax regulations.” Our consultants do not meet the employer-employee relationship as defined by the IRS and therefore are accounted for under ASC 718 as amended by ASU 2018-07. As such, the grant date is the measurement date of an award’s fair value. Corresponding expenses for employee and non-employee services are recognized over the requisite service period, which is typically the vesting period.

Treasury Stock

The Company accounts for treasury stock using the cost method. There were 497,587 shares of Class A common stock held in treasury, purchased at a total cumulative cost of approximately $49,759, as of ~~September~~March 3031, ~~2023~~2024 and December 31, ~~2022~~2023.

Recently Adopted Accounting Pronouncements

The FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326). This standard requires a financial asset to be presented at the net amount expected to be collected. We expect the financial assets of the Company in scope of ASU 2016-13 will primarily be accounts receivable. The Company will estimate an allowance for expected credit losses on accounts receivable that result from the inability of customers to make required payments. In estimating the allowance for expected credit losses, consideration will be given to the current aging of receivables, historical experience, and a review for potential bad debts. The Company adopted this guidance in the second quarter of fiscal 2023 and it did not have a material impact on its results of operations, financial position, and disclosures.

The Company does not believe that other standards, which have been issued but are not yet effective, will have a significant impact on its financial statements.

NOTE 4 - BASIC AND DILUTED NET LOSS PER COMMON SHARE:

Basic loss per common share is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding. Diluted loss per share is computed by dividing the net loss by the sum of the weighted-average number of shares of common stock outstanding plus the dilutive effect of shares issuable through the exercise of common stock equivalents.

We have excluded 6,909,000 common stock equivalents (warrants - Note 5) from the calculation of diluted loss per share for the ~~nine~~three months ended ~~September~~March 3031, ~~2023~~2024 and ~~2022~~2023, respectively, which, if included, would have an antidilutive effect.

Table of Contents

NOTE 5 - WARRANTS AND PREFERRED STOCKS:

Warrants

2023 Extension of Warrant Terms

The Company, acting by resolution of its Board of Directors, amended and extended the expiration date of its outstanding warrants to purchase up to 6,909,000 shares of common stock to March 7, 2026. The terms of the warrants, including the exercise price of $0.15 per share, remain in effect without modification. The warrants modification expense of $~~621~~345,~~810~~450 was recorded as the incremental value of the modified warrants over the unmodified warrants on the modification date. Assumptions used in the Black Scholes option-pricing model for these warrants were as follows:

Average risk-free interest rate	4.66	%
Average expected life-years	3
Expected volatility	182.19	%
Expected dividends	0	%

	Number ofWarrants			WeightedAverageExercisePrice		WeightedAverageRemainingContractualLife (Years)
Outstanding at December 31, 2022		6,909,000		$	0.15		0.18
Outstanding at December 31, 2023		6,909,000		$	0.15		2.18
Granted		—			—		—
Extended		~~6,909,000~~—			~~0.15~~—		~~3.00~~—
Exercised		—			—		—
Forfeited/expired		~~(6,909,000~~—	)		~~0.15~~—		—
Outstanding at September 30, 2023		6,909,000		$	0.15		2.44
Outstanding at March 31, 2024		6,909,000		$	0.15		1.93
Exercisable at September 30, 2023		6,909,000		$	0.15		2.44
Exercisable at March 31, 2024		6,909,000		$	0.15		1.93

As of ~~September~~March 3031, ~~2023~~2024 and December 31, ~~2022~~2023, the average remaining contractual life of the outstanding warrants was 21.4493 years and 02.18 year, respectively. The warrants will expire on March 7, 2026. The intrinsic value of the warrants at ~~September~~March 3031, ~~2023~~2024 was $0276,360 due to the ~~exercise~~fair ~~price~~market value exceeding the ~~fair~~exercise ~~market~~price ~~value~~ of the common stock.

Series A 10% Convertible Preferred Stock

The Company has authorized 4,000,000 shares of Preferred Stock, of which 50,000 shares have been designated as Series A 10% Convertible Preferred Stock. As of ~~September~~March 3031, ~~2023~~2024 and December 31, ~~2022~~2023, there was no preferred stock issued or outstanding.

NOTE 6 - STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION:

At ~~September~~March 3031, ~~2023~~2024 and December 31, ~~2022~~2023, the Company had 61,882,172 common shares outstanding. Also outstanding were warrants relating to 6,909,000 shares of common stock, all totaling 68,791,172 shares of common stock and all common stock equivalents, outstanding at ~~September~~March 3031, ~~2023~~2024 and December 31, ~~2022~~2023.

The Company did not incur any stock-based compensation or issue common or preferred stock or any other equity instruments during the ~~nine~~three months ended ~~September~~March 3031, ~~2023~~2024 and ~~2022~~2023.

NOTE 7 - FAIR VALUE MEASUREMENTS:

ASC 820, “Fair Value Measurements and Disclosure,” (“ASC 820”) defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, not adjusted for transaction costs. ASC 820 also establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels giving the highest priority to quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3).

Table of Contents

The three levels are described below:

Level 1 Inputs - Unadjusted quoted prices in active markets for identical assets or liabilities that is accessible by the Company;

Level 2 Inputs - Quoted prices in markets that are not active or financial instruments for which all significant inputs are observable, either directly or indirectly;

Level 3 Inputs - Unobservable inputs for the asset or liability including significant assumptions of the Company and other market participants.

There were no transfers in or out of any level during the ~~nine~~three months ended ~~September~~March 3031, ~~2023~~2024 or ~~2022~~2023.

Except for those assets and liabilities which are required by authoritative accounting guidance to be recorded at fair value in the Company’s balance sheets, the Company has elected not to record any other assets or liabilities at fair value, as permitted by ASC 820. No events occurred during the ~~nine~~three months ended ~~September~~March 3031, ~~2023~~2024 or ~~2022~~2023 which would require adjustment to the recognized balances of assets or liabilities which are recorded at fair value on a nonrecurring basis.

The Company determines fair values for its investment assets as follows:

Cash equivalents at fair value - the Company’s cash equivalents, at fair value, consist of money market funds - marked to market on reporting dates. The Company’s money market funds are classified within Level 1 of the fair value hierarchy since they are valued using quoted market prices from an exchange.

The following tables provide information on those assets measured at fair value on a recurring basis as of ~~September~~March 3031, ~~2023~~2024 and December 31, ~~2022~~2023, respectively:

	CarryingAmount InBalance SheetSeptember 30,		Fair ValueSeptember 30,		Fair Value Measurement Using
	CarryingAmount InBalance SheetMarch 31,		Fair ValueMarch 31,		Fair Value Measurement Using
	2023		2023		Level 1		Level 2		Level 3
	2024		2024		Level 1		Level 2		Level 3
Assets:
Treasury and government securities	$	~~388~~295,~~035~~216	$	~~388~~295,~~035~~216	$	~~388~~295,~~035~~216	$	—	$	—
Money market funds		1456,~~048~~172		1456,~~048~~172		1456,~~048~~172		—		—
Total Assets	$	~~402~~351,~~083~~388	$	~~402~~351,~~083~~388	$	~~402~~351,~~083~~388	$	—	$	—

	CarryingAmount InBalance SheetDecember 31,		Fair ValueDecember 31,		Fair Value Measurement Using
	2022		2022		Level 1		Level 2		Level 3
	2023		2023		Level 1		Level 2		Level 3
Assets:
Treasury and government securities	$	~~300~~378,~~000~~450	$	~~300~~378,~~000~~450	$	~~300~~378,~~000~~450	$	—	$	—
Money market funds		~~141~~9,~~243~~721		~~141~~9,~~243~~721		~~141~~9,~~243~~721		—		—
Total Assets	$	~~441~~388,~~243~~171	$	~~441~~388,~~243~~171	$	~~441~~388,~~243~~171	$	—	$	—

NOTE 8 - COMMITMENTS AND CONTINGENCIES:

The Company’s Board of Directors has agreed to pay the Company’s Chief Financial Officer an annual salary of $17,000. No other officers or directors of the Company receive cash compensation other than reimbursement of out-of-pocket expenses incurred in connection with Company business and development.

NOTE 9 - SUBSEQUENT EVENTS:

~~The~~On ~~Company~~February ~~has~~7, ~~evaluated~~2024, ~~subsequent~~the ~~events~~Company ~~from~~signed ~~September~~a ~~30,~~non-binding ~~2023~~indication ~~through~~of interest to acquire the ~~issuance~~three ~~date~~subsidiaries of ~~these~~Roseville ~~financial~~Partners, ~~statements~~LLC, a privately owned company. The indication of interest has now expired and has not been extended. While the Company may continue discussions with Roseville, there ~~are~~can be no ~~events~~assurance ~~requiring~~or ~~disclosure~~expectation that the parties will enter into definitive agreements. A press release announcing the expiration of the indication of interest was issued April 29, 2024.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-Looking Statements

The information in this report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. This Act provides a “safe harbor” for forward-looking statements to encourage companies to provide prospective information about themselves provided they identify these statements as forward looking and provide meaningful cautionary statements identifying important factors that could cause actual results to differ from the projected results. All statements other than statements of historical fact made in this report are forward-looking. In particular, the statements herein regarding future results of operations or financial position are forward-looking statements. Forward-looking statements reflect management’s current expectations and are inherently uncertain. The Company’s actual results may differ significantly from management’s expectations as a result of many factors.

You should read the following discussion and analysis in conjunction with the financial statements of the Company, and notes thereto, included herewith. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of management. The Company assumes no obligations to update any of these forward-looking statements.

Results of Operations

For the three months ended ~~September~~March 3031, ~~2023~~2024 and ~~2022~~2023

Revenue

The Company had no operations and no revenue for the three months ended ~~September~~March 3031, ~~2023~~2024 and ~~2022~~2023, and its only income was from interest income on its short-term investments which are classified as cash and cash equivalents.

Operating Expenses

The following table presents our total operating expenses for the three months ended ~~September~~March 3031, ~~2023~~2024 and ~~2022~~2023.

	Three months EndedSeptember 30,
	Three Months EndedMarch 31,
	2023		2022
	2024		2023
Audit, accounting and legal fees	$	226,~~700~~889	$	76,000
Payroll		5,~~235~~280		5,~~212~~237
Other general and administrative expense		46,~~193~~968		34,~~334~~602
	$	1239,~~128~~137	$	15,~~546~~839

Operating expenses ~~decreased~~increased by $323,~~418~~298 for the three months ended ~~September~~March 3031, ~~2023~~2024 as compared to the three months ended ~~September~~March 3031, ~~2022~~2023. The ~~decrease~~increase was related to the ~~decrease~~increase in legal and professional fees for the three months ended ~~September~~March 3031, ~~2023~~2024.

Other general and administrative expenses are comprised of transfer agent and EDGAR filer services and other services. These expenses were directly related to the maintenance of the corporate entity and the preparation and filing of reports with the Securities and Exchange Commission.

Loss from Operations

The Company incurred a loss from operations of $1239,~~128~~137 and $15,~~546~~839 for the three months ended ~~September~~March 3031, ~~2023~~2024 and ~~2022~~2023, respectively.

Other Income (Expense)

The following table presents our total Other Income (Expense) for the three months ended September 30, 2023 and 2022.

	Three months EndedSeptember 30,
	2023		2022
Interest and other income	$	3,018	$	1,688
Other Income (Expense)	$	3,018	$	1,688

Other income increased by $1,330 for the three months ended September 30, 2023 as compared to the three months ended September 30, 2022. The increase was related to the increase in interest and other income for the three months ended September 30, 2023.

Table of Contents

Net Loss

The Company had a net loss of $9,110 for the three months ended September 30, 2023, compared with a net loss of $13,858 for the three months ended September 30, 2022. Decrease in net loss was due primarily to the decrease in professional fee.

Loss per share for the three months ended September 30, 2023 and 2022 was approximately $(0.00) and $(0.00) based on the weighted-average shares issued and outstanding.

For the nine months ended September 30, 2023 and 2022

Revenue

The Company had no operations and no revenue for the nine months ended September 30, 2023 and 2022, and its only income was from interest income on its short-term investments which are classified as cash and cash equivalents.

Operating Expenses

The following table presents our total operating expenses for the nine months ended September 30, 2023 and 2022.

	Nine months EndedSeptember 30,
	2023		2022
Audit, accounting and legal fees		19,670		20,741
Payroll		15,585		15,541
Other general and administrative expense		13,741		11,126
	$	48,996	$	47,408

Operating expenses increased by $1,588 for the nine months ended September 30, 2023 as compared to the nine months ended September 30, 2022. The increase was related to the increase in other general and administrative expenses for the nine months ended September 30, 2023.

Loss from Operations

The Company incurred a loss from operations of $48,996 and $47,408 for the nine months ended September 30, 2023 and 2022, respectively.

Other Income (Expense)

The following table presents our total Other Income (Expense) for the ~~nine~~three months ended ~~September~~March 3031, ~~2023~~2024 and ~~2022~~2023.

	Nine months EndedSeptember 30,
	Three Months EndedMarch 31,
	2023			2022
	2024			2023
Interest and other income	$	93,~~458~~866		$	12,~~966~~353
Warrants modification expense		~~(621,810~~—	)		—(621,810	)
Other Income (Expense)	$	~~(612~~3,~~352~~866	)	$	1(619,~~966~~457	)

Other income ~~decreased~~increased by $~~614~~623,~~318~~323 for the ~~nine~~three months ended ~~September~~March 3031, ~~2023~~2024 as compared to the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023. The ~~decrease~~increase ~~in other income~~ was related to the ~~increase~~decrease in warrants modification expense for the ~~nine~~three months ended ~~September~~March 3031, ~~2023~~2024.

12 Table of Contents

Net Loss

The Company had a net loss of $~~661~~35,~~348~~271 for the ~~nine~~three months ended ~~September~~March 3031, ~~2023~~2024, compared with a net loss of $45635,~~442~~296 for the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023. ~~Increase~~Decrease in net loss was due primarily to the ~~increase~~decrease in warrants modification expense, offset by the increase in professional fee.

Loss per share for the ~~nine~~three months ended ~~September~~March 3031, ~~2023~~2024 and ~~2022~~2023 was approximately $(0.0100) and $(0.0001) based on the weighted-average shares issued and outstanding.

It is anticipated that future operating expenses will decrease and then stabilize as the Company complies with its periodic reporting requirements; however, expenses may increase as the Company works to effect a business combination, although there can be no assurance that the Company will be successful in effecting a business combination.

Liquidity and Capital Resources

At ~~September~~March 3031, ~~2023~~2024 the Company had cash and cash equivalents of $~~402~~351,~~083~~388, consisting of money market funds and U.S. Treasury and government securities maturing in 3 months or less. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.

The following table provides detailed information about our net cash flow for all years presented in this Report.

Cash Flow

	Nine months EndedSeptember 30,
	Three Months EndedMarch 31,
	2023			2022
	2024			2023
Net cash used in operating activities	$	(3936,~~160~~783	)	$	(459,~~442~~736	)
Net cash provided by investing activities		—			—
Net cash provided by financing activities		—			—
Net decrease in cash and cash equivalents	$	(3936,~~160~~783	)	$	(459,~~442~~736	)

Net cash of $3936,~~160~~783 and $459,~~442~~736 were used in operations during the ~~nine~~three months ended ~~September~~March 3031, ~~2023~~2024 and ~~2022~~2023, respectively.

The cash used in operating activities of $3936,~~160~~783 for the ~~nine~~three months ended ~~September~~March 3031, ~~2023~~2024 principally resulted from our net loss of $~~661~~35,~~348,~~279 asoffset ~~adjusted~~by ~~for~~change ain ~~non-cash~~accounts ~~charge~~payable ~~for~~and ~~warrants~~accrued ~~modification~~expenses ~~expense~~ of $~~621~~1,~~810~~504.

The cash used in operating activities of $459,~~442~~736 for the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023 principally resulted from our net loss of $45635,~~442~~296, as adjusted for a non-cash charge for warrants modification expense of $621,810, and a change in accounts payable and accrued expenses of $3,750.

No12 ~~cash~~Table ~~flows~~of ~~were used in or provided by investing activities during the nine months ended September 30, 2023 and 2022.~~Contents

No cash flows were used in or provided by ~~financing~~investing activities during the ~~nine~~three months ended ~~September~~March 3031, ~~2023~~2024 and ~~2022~~2023.

No cash flows were used in or provided by financing activities during the three months ended March 31, 2024 and 2023.

New Accounting Pronouncements

Refer to the discussion of recently adopted/issued accounting pronouncements under Note 3 - Significant Accounting Policies and Recent Accounting Pronouncements.

Factors Which May Affect Future Results

Future earnings of the Company are dependent on interest rates earned on the Company’s invested balances and expenses incurred. The Company expects to incur significant expenses in connection with its objective of identifying a merger partner or acquiring an operating business.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

Not applicable.

13 Table of Contents

Item 4. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures.

Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures. The term “disclosure controls and procedures,” as defined in Rules 13a-15I and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports, such as this report, that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on that evaluation, our chief executive officer and chief financial officer concluded that as of ~~September~~March 3031, ~~2023~~2024, our disclosure controls and procedures were effective.

Changes in Internal Controls over Financial Reporting.

We regularly review our system of internal control over financial reporting.

During the quarter ended ~~September~~March 3031, ~~2023~~2024, there were no changes in our internal controls over financial reporting that have materially affected, or are reasonably likely to affect materially, our internal control over financial reporting.

1413 Table of Contents

PART II. OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

Item 6. Exhibits.

Number		Description

31.1*		Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*		Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).

101.SCH		Inline XBRL Taxonomy Extension Schema Document.

101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB		Inline XBRL Taxonomy Extension Labels Linkbase Document.

101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

_____________

* Filed herewith

1514 Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	CHASE PACKAGING CORPORATION
Date: November 14, 2023	By:	/s/ Ann C. W. Green
Date: May15, 2024	By:	/s/ Ann C. W. Green
		Ann C. W. Green
		Chief Financial Officer and Assistant Secretary
		(Principal Executive, Financial and Accounting Officer)

1615

Filing Compare · CHASE PACKAGING CORP